I received a M.D. from Tel-Aviv University, Israel. I did residency in Internal Medicine at the Beth Israel Deaconess Medical Center (Harvard Medical School) followed by fellowship in Infectious Diseases at Stanford. I then pursued a research postdoctoral fellowship at Stanford (mentors: Dr. Jeffrey Glenn and Dr. Stephen Quake). I joined the faculty at Stanford in Sept 2011.
I joined the lab as a Research Associate in 2011. My research aims at better understanding the interplay between viruses and the host and identifying host proteins or pathways that play critical roles in multiple viral infections as potential targets for broad-spectrum antiviral therapy. My current projects focus on the role of the ESCRT machinery in intracellular envelopment of RNA viruses, regulation of viral infections by ubiquitination, and more.
I joined the lab in Oct 2016 as a graduate stuent in Microbiology and Immunology (ARTS program) and as an infectious diseases fellow. My work focuses on monitoring immune responses in the course of natural dengue infection and on investigating the pathogenesis of Zika virus induced apoptosis.
I joined the Einav lab in July 2016 as a postdoctoral fellow after receiving a PhD in Microbiology and Molecular Genetics from the Hebrew University of Jerusalem (Mentor: Prof. Hanna Engelberg-Kulka). During my PhD I studied quorum-sensing mechanisms. In the Einav lab I am working on the development of repurposed and novel kinase inhibitos to combat emerging viral infectious diseaes and on the role of ubiquitination in the viral lifecycle.
I joined the Einav lab as a Postdoctoral Fellow in 2014 after completing my PhD in the National Health Research Institute in Taiwan. My graduate studies focused on developing reverse-genetics systems for Flaviviruses. In the Einav lab, I am working on developing new tools to track Flaviviridae trafficking by advanced live cell imaging approaches and on developing next-generation selective kinase inhibitors as a broad-spectrum antiviral strategy.
I am a first year medical student pursuing an MD/PhD. I study the interactions between the HCV proteome and actin-related proteins. The end goal of this work is to discover novel ways in which actin dynamics are co-opted by HCV for entry, replication, assembly, and release. We hope to exploit these for novel therapeutics targeted to host proteins as well as enhance understanding of the viral life cycle.
I joined the Einav lab in February 2015 as a postdoctoral research after receiving my PhD on molecular virology of HCV from the University of Strasbourg. In the Einav lab my work has focused on better understanding the roles of adaptor protein complexes in intracellular trafficking of HCV and viral persistence. I am currently studying viral evoultion under host-targeted approaches and help the development of rnovel kinase inhibitos to combat dengue.
Gregory Neveu, PhD, Postdoctoral fellow, 03/2011-06/2015, Current position: senior virologist in the Virology Unit at Sanofi Pasteur
Elena Bekerman, PhD, Postdoctoral fellow, 08/2013-10/2016, Current position: Research Scientist, Department of Clinical Virology, Gilead Sciences, Inc.
Stanley Wang, MD/PhD, Postdoctoral fellow, 07/2012-01/2014. Current position: HCV Antivirals Development Department, ABBvie.
Amotz Ziv-Av, PhD, Postdoctoral fellow, 09/2011-09/2012, Current position: Research Associate, Bar-Ilan University, Israel
Yuan Jin Tan, Undergraduate student (Honor Thesis), 04/2014-08/2016, currently a PhD candidate at Stanford Micrpobiology and Immunology